Director, Global Medical Affairs, External Engagements

This role is considered Hybrid.

Job Summary:

The Director, Global Medical Affairs, External Engagements is a key leadership role responsible for driving the overarching global engagement strategy with the cardiovascular community. This role ensures the alignment of and partnership with opinion leaders, organizations, patient advocacy groups, and professional societies' input with evidence generation, global advisory needs, and strategic initiatives across medical affairs functions. The position is instrumental in shaping external engagement at a global level, ensuring consistency and excellence in execution.

Key Responsibilities:

Global KOL Engagement Strategy:

• Develop and execute the overarching global KOL engagement strategy and framework to support global evidence generation initiatives, advisory boards, and medical input on strategic priorities.
• Identify, prioritize, and cultivate relationships with global KOLs, aligning global engagement plan with therapeutic area objectives.

• Employ novel engagement tactics and platforms aligned with organizational goals

• Collaborate cross-functionally to ensure insights from KOLs are integrated into evidence generation, publications, and global medical strategies.

Professional Society Engagements:

• Define and execute a global strategy for engaging with professional societies and key congresses, ensuring alignment with overarching therapeutic area goals.
• Drive strategic interactions with societies, fostering opportunities for collaboration, such as guideline development, educational and research initiatives, and thought leadership.

Patient Advocacy Groups Engagement:

• Define and execute a global patient-centric strategy.
• Drive inclusion of the patient voice in global medical affairs tactical plans.
• Drive strategic interactions through regional advocacy leads to ensure inclusion and consistency.

Partnerships:

• Drive innovative partnerships that help enhance the organizational CV footprint

Cross-Functional Collaboration:

• Partner with Executive leadership, clinical development, market access, and regional medical affairs teams to ensure alignment on external engagement priorities.
• Liase with and commercial leaders to ensure awareness of medical engagements.
• Act as the central point of contact for global external engagement initiatives, ensuring consistency and avoiding duplication of efforts.

Compliance and Excellence in Execution:

• Ensure all external engagement activities are conducted in compliance with company policies, industry standards, and regulatory requirements.
• Establish best practices and tools for global external engagement, providing training and support as needed to regional and local medical teams.

Qualifications:

• Advanced degree in a healthcare-related field (e.g., PharmD, MD, PhD).
• 7+ years of experience in medical affairs, with a focus on external engagement or strategic KOL management.
• Demonstrated success in leading global medical strategies and engaging with global KOLs, professional societies, and healthcare organizations.
• Strong understanding of the drug development lifecycle and evidence generation process.
• Excellent communication, organizational, and leadership skills with the ability to influence and collaborate across global teams.
• Deep understanding of compliance requirements and regulatory considerations for external engagement activities.

Key Competencies:

• Strategic thinking and ability to develop and implement global initiatives.
• Expertise in scientific exchange and the ability to align scientific strategies with business goals.
• Strong interpersonal skills and ability to build and maintain high-quality relationships with external and internal stakeholders.
• Proactive and solution-oriented mindset, with a focus on excellence in execution.

About Alnylam:Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by "interfering" with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality.

Our culture:Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we've been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as the #1 Large Employer by Boston Globe Top Places to Work in 2023 for the third consecutive year, one of Science Magazine's Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK - among others.

At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Qualified applicants will receive consideration for employment without regard to their race, color, religion, age, sex, sexual orientation, gender identity or expression, national origin, ethnicity, marital status, protected veteran status, disability, or any other characteristics prohibited by law.